Search Results - "Justis, Anna"
-
1
Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages
Published in Infection and immunity (01-10-2018)“…is an obligate intracellular bacterium and the etiological agent of Q fever. Successful host cell infection requires the type IVB secretion system (T4BSS),…”
Get full text
Journal Article -
2
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
Published in Cancer cell (10-01-2022)Get full text
Journal Article -
3
Manipulation of Host Cholesterol by Obligate Intracellular Bacteria
Published in Frontiers in cellular and infection microbiology (05-05-2017)“…Cholesterol is a multifunctional lipid that plays important metabolic and structural roles in the eukaryotic cell. Despite having diverse lifestyles, the…”
Get full text
Journal Article -
4
Interactions between the Coxiella burnetii parasitophorous vacuole and the endoplasmic reticulum involve the host protein ORP1L
Published in Cellular microbiology (01-01-2017)“…Summary Coxiella burnetii is a gram‐negative intracellular bacterium that forms a large, lysosome‐like parasitophorous vacuole (PV) essential for bacterial…”
Get full text
Journal Article -
5
Large-Scale Characterization and Functional Assessment of Adaptive Immunity in Patients with MGUS and SMM Reveals Significant Defects
Published in Blood (02-11-2023)“…Introduction Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) exhibit signs of immune dysregulation…”
Get full text
Journal Article -
6
Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM
Published in Blood (15-11-2022)Get full text
Journal Article -
7
Single-Cell RNA Sequencing of Rare Circulating Tumor Cells in Precursor Myeloma Patients Reveals Molecular Underpinnings of Tumor Cell Circulation
Published in Blood (15-11-2022)Get full text
Journal Article -
8
-
9
-
10
Abstract 796: Altered immune response to vaccination in patients with plasma cell premalignancy
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Introduction Patients with hematological malignancies, including multiple myeloma (MM), experience sub-optimal responses to SARS-CoV-2 vaccination…”
Get full text
Journal Article -
11
Recruitment and Function of Orp1L on the Coxiella burnetii Parasitophorous Vacuole
Published 01-01-2018“…Coxiella burnetii, the zoonotic agent of human Q fever and chronic endocarditis, is an obligate intracellular bacterial pathogen. The Coxiella intracellular…”
Get full text
Dissertation -
12
Abstract 2259: Predictive modeling of smoldering multiple myeloma progression to multiple myeloma by continuous variable analysis
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: Multiple myeloma (MM) is consistently preceded by two precursor conditions, monoclonal gammopathy of undetermined significance (MGUS)…”
Get full text
Journal Article -
13
Abstract 5277: Humoral SARS-CoV-2 response in asymptomatic precursor plasma cell dyscrasia patients: IMPACT study results
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: Patients with hematologic malignancies, including multiple myeloma (MM), experience worse SARS-CoV-2 infection outcomes and sub-optimal…”
Get full text
Journal Article -
14
Abstract 641: Single-cell RNA sequencing of rare circulating tumor cells in precursor myeloma patients reveals molecular underpinnings of tumor cell circulation
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Background: Multiple Myeloma (MM) is a hematological malignancy characterized by abnormal proliferation of terminally differentiated plasma cells…”
Get full text
Journal Article -
15
Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: Patients with hematological malignancies exhibit inferior response to SARS-CoV2 vaccination, compared to healthy individuals, however…”
Get full text
Journal Article